It was reported that a patient underwent an atrial flutter right (r-afl) with a thermocool® smart touch® sf bi-directional navigation catheter and post procedure the bwi product analysis lab identified a hole in the pebax.During the procedure, while ablating on the cavotricuspid ishmus (cti) line, the catheter was displayed on the carto 3 system as jumping.After the catheter was removed from the patient, there was a coating of blood discovered inside and on the tip of the catheter.The blood could not be cleaned off.The catheter was visually undamaged and the medical team could not tell if the blood was inside or outside of the device.There were no difficulties in maneuvering or removing the catheter.The medical team replaced the catheter and the procedure continued without further issues.No patient consequences were reported.
|
The product investigation was completed.Device evaluation details: the device was returned to biosense webster (bwi) for evaluation.A visual inspection and magnetic sensor functionality test of the returned device were performed following bwi procedures.Visual analysis revealed reddish material and a hole in the surface of the pebax.The device was connected to the carto 3 system and it was recognized and visualized correctly.No icon jumping issues or errors were observed.A manufacturing record evaluation was performed for the finished device 31025364l number, and no internal actions related to the reported complaint condition were identified.The foreign material observed in the pebax could be related to the magnetic issue reported by the customer; therefore, the customer complaint was confirmed.The root cause of the pebax damage could be related to the manipulation of the device during the procedure; however, this cannot be conclusively determined.It should be noted that product failure is multifactorial.As part of biosense webster¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|